Skip Navigation



American Journal of Epidemiology Advance Access published online on July 17, 2006
American Journal of Epidemiology, doi:10.1093/aje/kwj250
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
164/6/567    most recent
kwj250v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Allison, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allison, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.
Received December 9, 2005
Accepted March 20, 2006

ORIGINAL CONTRIBUTIONS

The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women

Matthew Allison 1 *, Cedric Garland 1, Rowan Chlebowski 2, Michael Criqui 1, Robert Langer 3, Lieling Wu 4, Hemant Roy 5, Anne McTiernan 4, and Lewis Kuller 6, for the Women's Health Initiative Investigators

1 University of California, San Diego, CA
2 Los Angeles Biomedical Research Institute, Torrance, CA
3 Geisinger Health Systems, Danville, PA
4 Fred Hutchinson Cancer Research Center, Seattle, WA
5 Northwestern University, Chicago, IL
6 University of Pittsburgh, Pittsburgh, PA

* To whom correspondence should be addressed.
Matthew Allison, E-mail: mallison{at}ucsd.edu


  Abstract

The purpose of this study was to test the hypothesis that aspirin use is associated with a decreased risk of incident colorectal cancer. From the Women's Health Initiative, 91,574 participants between the ages of 50 and 79 years at baseline in 1993-1998 provided details on aspirin use via interview using a standardized questionnaire and were subsequently followed annually for incident colorectal cancer during a period of over 6 years. For those persons who reported aspirin use, the type of compound, dose, and duration of use were recorded. Medical histories suggestive of colorectal cancers at the annual update were verified by medical record and pathology report review by trained local physician adjudicators. There were 631 confirmed cases of invasive cancer of the colon or rectum. There was no significant association between any aspirin use and risk for incident colorectal cancer (hazard ratio = 0.96, 95% confidence interval: 0.8, 1.2). Moreover, with no aspirin use as the referent category, there were no significant associations for duration of aspirin intake by category (<1, 1-<2, 2-<3, 3-<4, 4-<5, and ≥5 years) or for daily dosage by category (<165, 165-<300, 300-<495, or ≥495 mg).

Keywords: aspirin; colonic neoplasms; primary prevention; rectal neoplasms.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
A. Bardia, J. O. Ebbert, R. A. Vierkant, P. J. Limburg, K. Anderson, A. H. Wang, J. E. Olson, C. M. Vachon, and J. R. Cerhan
Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
J Natl Cancer Inst, June 6, 2007; 99(11): 881 - 889.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.